Introduction-Reference-Cited by-同舟云学术

Introduction

Published:2007-01 Issue: Volume:44 Page:1-3
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Jabbour Elias,Kantarjian Hagop

Publisher

Elsevier BV

Subject

Hematology

Reference42 articles.

1. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

2. Chronic myeloid leukemia—Advances in biology and new approaches to treatment;Goldman;N Engl J Med,2003

3. Chronic myeloid leukemia: Diagnosis and treatment;Quintas-Cardama;Mayo Clin Proc,2006

4. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia;Barnes;Acta Haematol,2002

5. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-α: Follow-up results;Kantarjian;Clin Cancer Res,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caractéristiques préthérapeutiques et évolutives des patients atteints de la leucémie myéloïde chronique à Abidjan Côte d’Ivoire;Bulletin du Cancer;2019-06

2. Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis – Does MTHFR Polymorphism Matter;Case Reports in Oncology;2018-07-16

3. ‘Gatekeeper’ mutation in patients with chronic myeloid leukemia resistant to imatinib therapy: effect on survival;The Egyptian Journal of Haematology;2018

4. Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options;American Journal of Case Reports;2017-10-16

5. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy;Oncotarget;2017-02-16